Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Sun

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|April 29, 2009
North Korea halts foreign food-aid programmeEugene Sun Yim
Sports Medicine (Auckland, N.Z.)|May 16, 2013
Aortic root disease in athletes: aortic root dilation, anomalous coronary artery, bicuspid aortic valve, and Marfan's syndromeEugene Sun Yim
Sports Medicine (Auckland, N.Z.)|June 21, 2012
Ultrasound in sports medicine: relevance of emerging techniques to clinical care of athletesEugene Sun Yim, Gianmichael Corrado
The New England Journal of Medicine|January 11, 2023
Regimens for Drug-Resistant Tuberculosis. ReplyJuliano Timm, Angela M Crook, Eugene Sun
The Lancet. Infectious Diseases|October 31, 2024
Predictable excess hepatotoxicity in the SimpliciTB trial - Authors' replyMuge Cevik, Maria Beumont, Eugene Sun, et al.
HIV Clinical Trials|November 25, 2004
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infectionKit N Simpson, Michelle P Luo, Elinor Chumney, et al.
Clinical Therapeutics|November 20, 2015
Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and AgeRandall Hoover, Thomas Hunt, Michael Benedict, et al.
Clinical Therapeutics|January 1, 2016
Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy VolunteersRandall Hoover, Thomas Hunt, Michael Benedict, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2025
Pharmacokinetics, tolerability, and safety of TBI-223, a novel oxazolidinone, in healthy participantsAntonio Lombardi, Fran Pappas, Paul Bruinenberg, et al.
Antiviral Research|August 21, 2003
Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavirHongmei Mo, Liangjun Lu, Tatyana Dekhtyar, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|April 29, 2009
North Korea halts foreign food-aid programmeEugene Sun Yim
Sports Medicine (Auckland, N.Z.)|May 16, 2013
Aortic root disease in athletes: aortic root dilation, anomalous coronary artery, bicuspid aortic valve, and Marfan's syndromeEugene Sun Yim
Sports Medicine (Auckland, N.Z.)|June 21, 2012
Ultrasound in sports medicine: relevance of emerging techniques to clinical care of athletesEugene Sun Yim, Gianmichael Corrado
The New England Journal of Medicine|January 11, 2023
Regimens for Drug-Resistant Tuberculosis. ReplyJuliano Timm, Angela M Crook, Eugene Sun
The Lancet. Infectious Diseases|October 31, 2024
Predictable excess hepatotoxicity in the SimpliciTB trial - Authors' replyMuge Cevik, Maria Beumont, Eugene Sun, et al.
HIV Clinical Trials|November 25, 2004
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infectionKit N Simpson, Michelle P Luo, Elinor Chumney, et al.
Clinical Therapeutics|November 20, 2015
Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and AgeRandall Hoover, Thomas Hunt, Michael Benedict, et al.
Clinical Therapeutics|January 1, 2016
Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy VolunteersRandall Hoover, Thomas Hunt, Michael Benedict, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2025
Pharmacokinetics, tolerability, and safety of TBI-223, a novel oxazolidinone, in healthy participantsAntonio Lombardi, Fran Pappas, Paul Bruinenberg, et al.
Antiviral Research|August 21, 2003
Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavirHongmei Mo, Liangjun Lu, Tatyana Dekhtyar, et al.
Pageof 4